Galmed Pharmaceuticals LtdNASDAQ:GLMDNASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)
- LAST PRICE0.3139
- TODAY'S CHANGE (%)0.0059 (1.9156%)
- Bid / Lots0.2900/ 5
- Ask / Lots0.3200/ 4
- Open / Previous Close0.2970 / 0.3080
- Day Range
- 52 Week Range
- Volume6,150
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GLMD |
|---|---|---|
| 09:32 ET | 684 | 0.3126 |
| 09:41 ET | 875 | 0.3 |
| 10:24 ET | 100 | 0.3001 |
| 02:33 ET | 600 | 0.3155 |
| 02:36 ET | 2730 | 0.316907 |
| 03:05 ET | 500 | 0.3139 |
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Galmed Pharmaceuticals Ltd | 2.0M | -0.1x | --- |
Phio Pharmaceuticals Corp | 2.0M | -0.1x | --- |
Windtree Therapeutics Inc | 1.9M | 0.4x | --- |
Neximmune Inc | 1.9M | -0.1x | --- |
PaxMedica Inc | 1.9M | 0.0x | --- |
Dermata Therapeutics Inc | 1.8M | -0.1x | --- |
Company Information
Galmed Pharmaceuticals is a Israeli-based clinical-stage biopharmaceutical company.The activiti of the Company is focused on the development therapy for treating liver diseases. Arachmol, the main product of Galmed Pharmaceuticals, is a liver-targeted stearoyl-coenzyme A desaturase1 used in oral therapy for the treatment of NASH (Non-alcoholic Steatohepatitis).
Contact Information
- Headquarters
- 16 Tiomkin StreetTEL AVIV-YAFO, Israel 6578317
- Phone
- ---
- Fax
- ---
Executives
- President, Chief Executive Officer, Director
- Allen Baharaff
- Chief Financial Officer
- Doron Cohen
- Chief Operating Officer, Data Protection Officer
- Guy Nehemya
- Chief Accounting Officer
- Yohai Stenzler
- Chief Scientific Officer
- Liat Hayardeny
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $2.0M |
|---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 6.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.66 |
EPS | $-2.83 |
Book Value | $2.75 |
P/E Ratio | -0.1x |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
